Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 9;20(1):178.
doi: 10.1186/s13054-016-1361-y.

Adrenomedullin and endothelin-1 are associated with myocardial injury and death in septic shock patients

Oscar H M Lundberg  1 , Lill Bergenzaun  2 , Jörgen Rydén  2 , Mari Rosenqvist  3 , Olle Melander  4   5 , Michelle S Chew  5   6   7
Affiliations

Adrenomedullin and endothelin-1 are associated with myocardial injury and death in septic shock patients

Oscar H M Lundberg et al. Crit Care. .

Abstract

Background: Adrenomedullin and endothelin-1 are hormones with opposing effects on the cardiovascular system. Adrenomedullin acts as a vasodilator and seems to be important for the initiation and continuation of the hyperdynamic circulatory response in sepsis. Endothelin-1 is a vasoconstrictor and has been linked to decreased cardiac performance. Few studies have studied the relationship between adrenomedullin and endothelin-1, and morbidity and mortality in septic shock patients. High-sensitivity troponin T (hsTNT) is normally used to diagnose acute cardiac injury but is also prognostic for outcome in intensive care. We investigated the relationship between mid-regional pro-adrenomedullin (MR-proADM), C-terminal pro-endothelin-1 (CT-proET-1), and myocardial injury, measured using transthoracic echocardiography and hsTNT in septic shock patients. We were also interested in the development of different biomarkers throughout the ICU stay, and how early measurements were related to mortality. Further, we assessed if a positive biomarker panel, consisting of MR-proADM, CT-proET-1, and hsTNT changed the odds for mortality.

Methods: A cohort of 53 consecutive patients with septic shock had their levels of MR-proADM, CT-proET-1, hsTNT, and left ventricular systolic functions prospectively measured over 7 days. The relationship between day 1 levels of MR-proADM/CT-proET-1 and myocardial injury was studied. We also investigated the relationship between biomarkers and early (7-day) and later (28-day) mortality. Likelihood ratios, and pretest and posttest odds for mortality were calculated.

Results: Levels of MR-proADM and CT-proET-1 were significantly higher among patients with myocardial injury and were correlated with left ventricular systolic dysfunction. MR-proADM and hsTNT were significantly higher among 7-day and 28-day non-survivors. CT-proET-1 was also significantly higher among 28-day but not 7-day non-survivors. A positive biomarker panel consisting of the three biomarkers increased the odds for mortality 13-fold to 20-fold.

Conclusions: MR-proADM and CT-proET-1 are associated with myocardial injury. A biomarker panel combining MR-proADM, CT-proET-1, and hsTNT increases the odds ratio for death, and may improve currently available scoring systems in critical care.

Keywords: Adrenomedullin; Echocardiography; Endothelin-1; High-sensitivity troponin; Likelihood ratio; Mortality; Myocardial injury; Sepsis; Shock.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Temporal development of MR-proADM, CT-proET-1 and hsTNT
See this image and copyright information in PMC

References

    1. Samson WK, Resch ZT, Murphy TC, Vargas TT, Schell DA. Adrenomedullin: Is There Physiological Relevance in the Pathology and Pharmacology? News Physiol Sci. 1999;14:255–9. - PubMed
    1. Lainchbury JG, Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG. Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. J Clin Endocrinol Metab. 2000;85(3):1016–20. - PubMed
    1. Nicholls MG, Lainchbury JG, Lewis LK, McGregor DO, Richards AM, Troughton RW, et al. Bioactivity of adrenomedullin and proadrenomedullin N-terminal 20 peptide in man. Peptides. 2001;22(11):1745–52. doi: 10.1016/S0196-9781(01)00508-3. - DOI - PubMed
    1. Temmesfeld-Wollbruck B, Brell B, David I, Dorenberg M, Adolphs J, Schmeck B, et al. Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock. Intensive Care Med. 2007;33(4):703–10. doi: 10.1007/s00134-007-0561-y. - DOI - PubMed
    1. Hippenstiel S, Witzenrath M, Schmeck B, Hocke A, Krisp M, Krull M, et al. Adrenomedullin reduces endothelial hyperpermeability. Circ Res. 2002;91(7):618–25. doi: 10.1161/01.RES.0000036603.61868.F9. - DOI - PubMed

Publication types